• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

可手术肺癌的胸膜内卡介苗接种

Intrapleural BCG in operable lung cancer.

作者信息

Lowe J, Iles P B, Shore D F, Langman M J, Baldwin R W

出版信息

Lancet. 1980 Jan 5;1(8158):11-4. doi: 10.1016/s0140-6736(80)90551-6.

DOI:10.1016/s0140-6736(80)90551-6
PMID:6101353
Abstract

In a controlled randomised clinical trial of 92 patients with surgically resected lung cancer, intrapleural BCG had no clear effect on survival. Adverse effects were insignificant.

摘要

在一项针对92例接受手术切除肺癌患者的对照随机临床试验中，胸膜内注射卡介苗对生存率没有明显影响。不良反应不显著。

相似文献

1
Intrapleural BCG in operable lung cancer.可手术肺癌的胸膜内卡介苗接种
Lancet. 1980 Jan 5;1(8158):11-4. doi: 10.1016/s0140-6736(80)90551-6.
2
Regional immunotherapy of lung cancer with intrapleural B.C.G.卡介苗胸膜腔内注射对肺癌的区域免疫治疗
Lancet. 1976 Feb 21;1(7956):377-9. doi: 10.1016/s0140-6736(76)90212-9.
3
A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771.一项关于辅助性胸膜内卡介苗治疗肺T1N0、T1N1或T2N0期鳞状细胞癌、腺癌或大细胞癌患者的安慰剂对照随机双盲研究。肺癌研究组方案771。
Chest. 1994 Dec;106(6 Suppl):287S-292S.
4
Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).用卡介苗细胞壁骨架（BCG-CWS）对肺癌进行辅助免疫治疗。
Cancer. 1979 Apr;43(4):1314-9. doi: 10.1002/1097-0142(197904)43:4<1314::aid-cncr2820430420>3.0.co;2-6.
5
Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.对奥尔巴尼胸膜内注射卡介苗治疗肺癌经验的四年随访。
J Thorac Cardiovasc Surg. 1981 Apr;81(4):485-92.
6
Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group.I期非小细胞肺癌的手术辅助胸膜内卡介苗治疗。国立癌症研究所肺癌研究组的初步报告。
J Thorac Cardiovasc Surg. 1981 Nov;82(5):649-57.
7
[Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].[免疫疗法作为肺癌非小细胞癌手术治疗辅助手段的意义]
Gan To Kagaku Ryoho. 1985 Jan;12(1):13-20.
8
Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.用卡介苗牛型分枝杆菌细胞壁骨架进行肺癌的非特异性辅助免疫治疗。
Cancer Res. 1979 Aug;39(8):3262-7.
9
[Three cases of panpleuro-pneumonectomy with intrapleural BCG for the treatment of advanced lung cancer (author's transl)].胸膜全肺切除术联合胸腔内卡介苗治疗晚期肺癌三例（作者译）
Nihon Kyobu Geka Gakkai Zasshi. 1979 Jun;27(6):936-42.
10
Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.肺癌术后胸膜腔内注射卡介苗：5年随访报告
Cancer Immunol Immunother. 1986;22(2):155-9. doi: 10.1007/BF00199131.

引用本文的文献

1
Beyond Tuberculosis: The Surprising Immunological Benefits of the Bacillus Calmette-Guérin (BCG) Vaccine in Infectious, Auto-Immune, and Inflammatory Diseases.超越结核病：卡介苗（BCG）疫苗在感染性、自身免疫性和炎症性疾病中令人惊讶的免疫学益处
Pathogens. 2025 Feb 15;14(2):196. doi: 10.3390/pathogens14020196.
2
Evaluation of the effects of postoperative pleural empyema on survival rates of patients after pneumonectomy due to non-small cell lung cancer.评估术后胸膜脓胸对非小细胞肺癌肺切除术后患者生存率的影响。
Kardiochir Torakochirurgia Pol. 2024 Mar;21(1):1-7. doi: 10.5114/kitp.2024.138376. Epub 2024 Mar 30.
3
Efficacy of Bacillus Calmette-Guérin in Cancer Prevention and Its Putative Mechanisms.
卡介苗在癌症预防中的功效及其可能机制。
J Cancer Prev. 2024 Mar 30;29(1):6-15. doi: 10.15430/JCP.23.036. Epub 2024 Mar 29.
4
Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.肺癌术后胸膜腔内注射卡介苗：缺乏疗效且可能促进肿瘤生长。
Thorax. 1981 Nov;36(11):870-4. doi: 10.1136/thx.36.11.870.
5
Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.特异性和非特异性免疫疗法作为肺癌根治性手术的辅助治疗手段。
Yale J Biol Med. 1981 Sep-Oct;54(5):367-79.
6
Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.可切除鳞状细胞肺癌的区域免疫治疗。一项随机研究的分析。
Cancer Immunol Immunother. 1982;13(3):174-5. doi: 10.1007/BF00205383.
7
Manipulation of host resistance in cancer therapy.癌症治疗中宿主抵抗力的调控。
Springer Semin Immunopathol. 1982;5(2):113-25. doi: 10.1007/BF00199791.
8
Tuberculous peritonitis developing in a case of documented peritoneal carcinomatosis.在一例已确诊的腹膜癌病例中发生了结核性腹膜炎。
West J Med. 1985 Jul;143(1):103-5.
9
Adjuvant specific immunotherapy of resectable squamous cell lung carcinoma. Analysis at the eighth year.可切除鳞状细胞肺癌的辅助特异性免疫治疗。八年分析。
Cancer Immunol Immunother. 1985;20(3):231-5. doi: 10.1007/BF00205582.
10
Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.肺癌术后胸膜腔内注射卡介苗：5年随访报告
Cancer Immunol Immunother. 1986;22(2):155-9. doi: 10.1007/BF00199131.